Global Preterm Birth And PROM Testing Market Research Report 2021-2028: Focus on Pelvic Exam, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitazine Test, Ferning Test, Pooling
December 07, 2021 07:28 ET
|
Research and Markets
Dublin, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The "Global Preterm Birth And PROM Testing Market Size, Share & Trends Analysis Report by Test Type (Pelvic Exam, Ultrasound, Biochemical Markers,...
CenteringPregnancy Recognized by Michigan Council for Maternal and Child Health as Promising Prenatal Care Model to Improve Outcomes and Promote Health Equity in State
April 29, 2021 16:16 ET
|
Centering Healthcare Institute
LANSING, Michigan, April 29, 2021 (GLOBE NEWSWIRE) -- Centering Healthcare Institute (CHI) today shared that the CenteringPregnancy® model of group prenatal care has been recognized by the Michigan...
Health Care Service Corporation and Centering Healthcare Institute Expand Access to CenteringPregnancy® Prenatal Care to 30 Safety Net Health Care Clinics Across Five States
March 03, 2020 12:28 ET
|
Centering® Healthcare Institute
Boston, March 03, 2020 (GLOBE NEWSWIRE) -- The nation’s largest customer-owned health insurer, Health Care Service Corporation (HCSC), is teaming up with Centering Healthcare Institute (CHI), a...
Analysis Finds Evidence-based CenteringPregnancy® Model Reduces Racial and Social Disparities Across Maternal Child Health
October 02, 2019 11:26 ET
|
Centering® Healthcare Institute
Boston, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Centering Healthcare Institute (CHI) today released its latest issue brief, “How CenteringPregnancy can Support Birth Equity,” which examines the need for...
Sera Prognostics Receives New York State Approval for PreTRM® Testing
December 12, 2018 08:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s health company, announced today that the New York State Department of Health has issued a clinical laboratory...
Sera Prognostics Completes Enrollment of Large, Multicenter, Prospective Clinical Study of PreTRM® Test
November 27, 2018 08:00 ET
|
Sera Prognostics, Inc.
TREETOP Study will Explore Enhancements to Sera’s Validated PreTRM® Test SALT LAKE CITY, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s health company, announced today that...
Sera Prognostics Appoints Dr. Garrett K. Lam as Chief Medical Officer
June 21, 2018 10:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, June 21, 2018 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, announced today that Garrett K. Lam, M.D., FACOG, will be joining the company as chief medical...
Sera Prognostics Collaborates with Christiana Care Health System to Launch New Preterm Birth Study with PreTRM® Test
June 19, 2018 10:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, June 19, 2018 (GLOBE NEWSWIRE) -- Sera Prognostics, a women’s health company, announced today that the first patient has been enrolled in the AVERT PRETERM TRIAL. This is the second...
Sera Prognostics to Present at the 11th Annual Canaccord Genuity Medical Technologies and Diagnostics Forum
November 06, 2017 10:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Sera Prognostics to Present at the Baird 2017 Global Healthcare Conference
September 05, 2017 10:49 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive...